Serum sensitivity testing 110
Serum sensitivity of borrelial strains was assessed employing a growth inhibition assay as 111 previously described (6, 27, 36) . Briefly, highly motile spirochetes (1.25 × 10 7 ) diluted in a 112 final volume of 100 µl in BSK medium containing 240 µg ml -1 phenol red were incubated 113 with 50% normal human serum (NHS) or 50% heat-inactivated human serum (hiNHS) in 114 microtiter plates for 10 days at 33°C (Costar, Cambridge, MA). Growth of spirochetes was 115 monitored by daily measuring of the indicator color shift of the medium at 562/630nm using 116 an ELISA reader (PowerWave 200, Bio-Tek Instruments, Winooski, VT). For calculation of 117 the growth curves, the Mikrowin Version 3.0 software (Mikrotek, Overath, Germany) was 118 used. 119 120
Immunofluorescence assay for detection of deposited complement components 121
For detection of activated complement components deposited on the borrelial surface, an 122 immunofluorescence assay was performed as previously described (19) . In brief, spirochetes 123
(6 x 10 6 ) were incubated in 25% NHS or, as a control, in 25% hiNHS for 30min at 37°C with 124 gentle agitation. Ten microliters cell suspensions were spotted on glass slides, allowed to air 125 dry overnight, and fixed in methanol. After 1h incubation at 37°C with polyclonal antibodies 126 directed against the complement components C3 (Calbiochem), C6 (Calbiochem) or a mAb 127 directed against C5b-9 (Quidel), slides were washed and subsequently incubated with Alexa 128 488-conjugated antibodies directed against either goat or mouse antibodies (Molecular 129 incubation at room temperature and four washes with PBSA (0.15 M NaCl, 0.03 M 136 phosphate, 0.02% sodium azide, pH 7.2) containing 0.05% Tween-20, proteins bound to the 137 cells` surface were eluted with 100 mM glycine-HCl (pH 2.0) for 15 min. Cells were removed 138 by centrifugation at 14.000 x g for 10 min at 4°C, and both the supernatant and the last wash 139
were separated by Laemmli-SDS-PAGE under non-reducing conditions and analyzed by 140 Western blotting as previously described (19) . 141 142
Opsonization of borrelial cells and analysis of covalently bound C3 fragment 143
Spirochetes from logarithmic phase cultures were harvested, washed threefold and 144 resuspended in veronal buffered saline (VBS). Opsonization was carried out by incubation of 145 borrelial cells (2 x 10 8 ) in either 10% NHS, 10% NHS-EGTA, or 10% NHS-EDTA for 30 146 min at 37 ºC. To differentiate between the classical or alternative pathway of complement 147 activation, NHS had been preincubated for 30 min at 37 ºC either with 10 mM EGTA, 4 mM 148 MgCl 2 in VBS to specifically inactivate the classical pathway or with 10 mM EDTA to 149 abolish activation of both the classical and alternative pathway. Noncovalently bound C3 was 150 removed by washing the spirochetes with PBS containing 500 mM NaCl. Activated and 151 covalently bound C3 was subsequently eluted from the borrelial surface by incubation of the 152 cells in 1 M hydroxylamine, 0.2 M Na 2 CO 3 (pH 11) for 60 min at 37 ºC. After centrifugation, 153 the supernatants were adjusted to pH 7.0 by adding 2M HCl, separated by Laemmli-SDS-154 PAGE under reducing conditions and analyzed by Western blotting as previously described 155 (19) . 156 at room temperature. After washing, human C3b (Calbiochem) and human Factor I 162 (Calbiochem) were added to the cells and the reaction mixtures were incubated for 60 min at 163 37 ºC. The cells were sedimented by centrifugation and the supernatants were mixed with 164 sample buffer, subjected to SDS-PAGE under reducing conditions and transferred onto a 165 nitrocellulose membrane. C3b degradation products were visualized by Western blotting 166 using a polyclonal goat anti-C3 IgG (Calbiochem) (dilution 1/2,000) and 3, 3',5,5'-167 Tetramethylbenzidine as substrate. 168 169
Enzyme-linked immunosorbent assay 170
Binding of CFH, CFHR1, and FHL1 to recombinant borrelial proteins was analyzed by 171 ELISA as described previously (52). Briefly, purified GST fusion proteins were immobilized 172 onto microtiter plates overnight at 4 °C and unspecific binding sites were blocked with 0.2 % 173 gelatin in PBS for 6 h at 4 °C. CFH (Calbiochem), CFHR1 or FHL1 (5µg/ml each) were 174 added to the wells and incubated overnight at 4 °C. After washing with PBS, protein 175 complexes were identified using a polyclonal goat anti-CFH antibody followed by a 176 secondary peroxidase-conjugated anti-goat IgG antibody. The reaction was developed with 177 1,2-phenylenediamine dihydrochloride (Sigma-Aldrich). 178
179

SDS-PAGE, ligand affinity blot and Western blot analysis 180
Whole cell lysates obtained from each borrelial isolate or from purified recombinant proteins 181 (500 ng per lane) were subjected to 10 % Tris/Tricine-SDS-PAGE under reducing conditions 182 and transferred to nitrocellulose as previously described (28). 183
184
PCR cloning and purification of recombinant proteins 185
Various oligonucleotides listed in Table 2 Expression of the GST-OspE fusion protein in E. coli JM109 and affinity purification on a 193 glutathione-sepharose column were performed as recommended by the manufacturer (GE 194 Healthcare, Freiburg, Germany). Generation of recombinantly expressed CspA, CspZ, and 195 ErpP proteins has been described elsewhere (15, 24, 25) . 196
197
Analysis of B. lusitaniae mRNA levels 198
Total RNA was extracted from cultured spirochetes (1 x 10 9 cells) grown to mid-log phase 199 using TRIzol reagent and Max Bacterial Enhancement Reagent (Invitrogen, Carlsbad, CA) 200 as described previously (8). Briefly, isolated RNA was resuspended in water and treated with 201 DNase I (Ambion, Austin, TX). Following inactivation of DNAse I using DNase Inactivation 202 Reagent (Ambion), a 1-µg aliquot of each DNA-free RNA preparation was reverse 203 transcribed using First Strand cDNA synthesis kit (Roche Diagnostic GmbH, Mannheim, 204 Germany) with random hexamers and AMV reverse transcriptase. As controls, reaction 205 mixtures containing all components except AMV reverse transcriptase were prepared and 206 treated similarly. Templates and primers were annealed for 10 min at room temperature, 207 followed by cDNA synthesis at 42 °C for 1 h. Reverse transcriptase was inactivated by 208 incubating the reaction mixtures at 95 °C for 5 min, followed by 10 min at 4 °C. All cDNAs 209 and appropriate controls were diluted 10-fold before being used as templates for RT-PCR The deduced amino acid sequence of the OspE protein of B. lusitaniae MT-M8 was aligned 232 using DNAstar Lasergene 99 software package. The secondary structure prediction was 233 obtained using GOR4 (Garnier et al., 1996) To assess the sensitivity of B. lusitaniae to complement-mediated killing, 16 isolates of 239 different biological and geographical origins (Table 1) were grown in the presence of 50% 240 normal non-immune human serum (NHS) or in 50% heat-inactivated NHS (hiNHS) for up to 241 10 days. In the presence of NHS, growth of B. lusitaniae isolates, including the human isolate 242
PoHL, was strongly inhibited as evidenced by minor changes of absorbance values 243 (NHS/hiNHS ratios 2.8 -4.0) ( Table 1) released from the bacterial surface by using hydroxylamine and C3 degradation products 274 were analyzed by Western blotting. B. lusitaniae isolates showed no significant differences in 275 complement activation and C3b deposition (Fig. 2) . All isolates bound the 75 kDa β-chain 276 common to C3b and iC3b, the 68 kDa α´-chain of iC3b, and the 43 kDa α´-chain of C3c after 277 incubation with NHS ( Fig. 2A) . Presence of the 105 kDa α´-chain indicates deposition of 278 intact C3b on the cell surface. All B. lusitaniae isolates, B. garinii strain G1 and B. 279 burgdorferi strain B31-e2 activated C3, whereas no covalently-bound C3 was released from 280 the surface of B. spielmanii A14S and B. afzelii FEM1-D15. In addition, similar C3 281 fragmentation patterns were obtained from B. lusitaniae isolates, B. garinii G1 and B. 282 burgdorferi B31-e2 following incubation in NHS-EGTA indicating that these particular 283
Borrelia isolates activate complement predominately via the alternative pathway (Fig. 2B) . 284
Opsonization of C3 was undetectedable when B. spielmanii A14S and B. afzelii FEM1-D15 285 were incubated with EGTA-chelated NHS. The restricted complement activation of these 286 particular isolates could be explained either by efficient release of covalently bound C3 due to 287 binding of complement regulators or by inhibition of C3 deposition through the production of 288 on October 17, 2017 by guest http://iai.asm.org/ Downloaded from a slime layer as described previously (27) . As expected, when spirochetes were incubated 289 with EDTA-chelated serum, C3 was not activated (data not shown). Thus, all B. lusitaniae 290 isolates activated complement mainly by the alternative pathway. 291 292
Identification of serum proteins binding to B. lusitaniae 293
To further examine whether B. lusitaniae can bind to human serum proteins, in particular 294 members of the CFH family, borrelial cells were incubated in NHS-EDTA to avoid 295 complement activation, followed by extensive washings and elution of bound proteins from 296 the spirochetal surface using 0.1M glycine-HCl (pH 2.0). The last wash and the eluted 297 fraction were then separated by SDS-PAGE and subjected to Western blotting with a 298 polyclonal anti-CFH antiserum. A faint band of 150 kDa corresponding to CFH was detected 299 in the eluted fractions of all B. lusitaniae isolates (Fig. 3) . Isolates SDA1-N1, MT-M8, MT-300 W4, MT-W16, RBU Pm2-N6, RBU La5-L2, HHS La1-L3, and PoHL in addition bound 301 CFHR1α (43 kDa) and CFHR1β (37 kDa), the two glycosylated forms of CFHR1. Moreover, 302 isolate MT-M8 acquired CFHR2 (24 kDa) and its glycosylated form CFHR2α (29 kDa) to the 303 (Fig. 4) (14, 50) suggesting that the putative protein is lipidated and located at the outer 347 surface of the spirochetes. To confirm the surface localization of the 16 kDa protein, we 348 treated intact borrelial cells with proteolytic enzymes. Treatment with proteinase K at the 349 lowest concentration (2.5 µg/ml) led to a complete elimination of the 16 kDa band whereas 350 trypsin treatment had no effect (data not shown). Because the CFH-binding protein of 16 kDa 351 is readily accessible to proteinase K, it appears to be located on the outer surface of B. 352
lusitaniae. 353 354
Binding properties of the recombinant CFH-binding protein of B. lusitaniae MT-M8 355
To the CFH-binding protein of B. lusitaniae MT-M8, we analyzed its binding activity for 356 diverse members of the CFH protein family, in particular CFH, FHL1, and CFHR1. A GST-357 tagged fusion protein using oligonucleotides, provisionally termed OspE 55(+) BamHI and 358 OspE 3nc(-) XhoI was expressed (Table 2) . After cloning and overproduction in E. coli, 359 ligand affinity blotting and ELISA was performed to investigate binding of CFH, CFHR1, 360 and FHL1 (Fig. 6) . The recombinant OspE derived from B. lusitaniae MT-M8 failed to bind 361 FHL1 and CFHR1 and binding to CFH less efficiently as compared to CspA, CspZ, and ErpP 362 of B. burgdorferi s.s. LW2 (20, 21, 29, 30) (Fig. 6A) In order to examine expression levels of the ospE gene of B. lusitaniae in vitro, qRT-PCR 372 was performed. Total RNA isolated from each of the B. lusitaniae isolates grown to mid-373 logarithmic phase were reverse transcribed and cDNAs were subjected to qRT-PCR to 374 measure the ospE transcript levels. As depicted in Figure 7 , ospE was expressed in all isolates 375 however at different levels. As expected, ospE expression levels were lower as compared to 376 the expression of flaB (Fig. 7) hosts and ixodid tick vectors. The broad spectrum of reservoir hosts contributes differentially 402 to the prevalence of particular genospecies associated with distinct patterns of host 403 specialization (32, 33, 47) . A growing body of experimental evidence suggests that the 404 reservoir competence of a host for a particular borrelial species may be independent of 405 extrinsic ecological factors, but strongly correlates with the spirochetes' serum sensitivity 406 pattern to complement of a particular host group (32) (33) (34) 47) . For example, rodent-associated 407 B. afzelii is resistant to rodent complement, but sensitive to avian complement, whereas bird-408 associated B. valaisiana and most B. garinii react with the opposite serum sensitivity pattern 409 (32-34). B. burgdorferi s.s., on the other hand, is partially resistant to both, rodent and avian, 410 complement; and this genospecies is adapted to both groups of hosts (44, 48 are highly susceptible to complement-mediated killing (2, 4-6, 19, 26, 33, 34, 57) . Due to the 414 limited number of isolates that have been tested (4, 33), the resistance/sensitivity pattern of B. 415 lusitaniae to human complement remains largely unknown. The association of B. lusitaniae 416 with lizards as the most important reservoir hosts (13, 46, 58) implicates an adaptation of this 417 genospecies to their hosts' complement system. All B. lusitaniae isolates analyzed in the 418 present study were readily killed by complement-active human serum arguing for the inability 419 of this genospecies to infect and survive in the human host. However, B. lusitaniae has been 420 isolated from two Lyme disease patients suggesting that it may have some pathogenic 421 potential in humans (9-11). Of note, PoHL a human-derived isolate included in this study did 422 not show any differences concerning its serum susceptibility pattern as well as its capability 423 to bind complement regulatory proteins compared to the other B. lusitaniae isolates. Thus showed signs of cell destruction. Our observation on the bacteriolysis of B. lusitaniae in 458 human serum is in accord with previous findings indicating that serum-sensitive B. garinii 459 non-OspA serotype 4 strains were strongly affected by complement (27, 57) . 460 B. lusitaniae activates complement mainly via the alternative pathway, similar to the serum-461 sensitive B. garinii strains suggesting a major contribution of this pathway to opsonization of 462 B. lusitaniae with activated C3b (6, 56, 57) . However, the involvement of the classical or the 463 Lectin pathway cannot be completely excluded for complement activation of this particular 464 genospecies. Activation of both, alternative and classical pathway, in the absence of 465 antibodies has been described earlier for B. burgdorferi s.s. and B. afzelii strains (6, 56, 57) . 466 Seemingly, among Lyme disease spirochetes, B. afzelii, and B. spielmanii resist complement-467 mediated lysis more efficiently than all other borrelial genospecies. Furthermore, the absence 468 of covalently bound C3b on the cell surface of these particular genospecies and the reduced 469 capacity to activate complement via the classical and the alternative pathway might be 470 explained via the production of a slime layer as previously demonstrated for B. afzelii (27) or 471 by binding of complement regulators (19, 29) . 472 Serum-resistant, but not serum-sensitive, borreliae are able to control the activation of 473 complement by recruiting host derived fluid-phase complement regulators CFH and FHL1 (2, 474 29, 39, 54) . Interestingly, all B. lusitaniae isolates were able to bind CFH and some isolates 475 also bound CFHR1 and CFHR2 to their surface, although they are serum-sensitive. Evidently, 476 CFH bound to the spirochetal surface failed to protect cells from complement-mediated 477 killing. We therefore conclude that CFH bound inadequately to the surface of the pathogen or 478 the amount of surface bound CFH was insufficient to inactivate C3b or to accelerate the 479 decay of formed C3 convertase following activation of the complement cascade. In line with 480 this assumption, C3b inactivation products were undetectable following incubation of B. 481 lusitaniae with purified CFH. Either scenario may explain our observation that B. lusitaniae 482 accumulated levels of lethal complement activation products (C3, C6 and TCC) on their 483
surfaces. 484
Interaction of serum-resistant borreliae with CFH and FHL1 or CFHR1 is mediated by a 485 group of distinct outer surface proteins called CRASPs (1, 16, 18, 19, 28, 39, 54 
